title: Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes.
authors.affiliation: Laboratory for Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. dwsommeijer@hotmail.com
authors.forename: D W
authors.initials: DW
authors.lastname: Sommeijer
authors.forename: K
authors.initials: K
authors.lastname: Joop
authors.forename: A
authors.initials: A
authors.lastname: Leyte
authors.forename: P H
authors.initials: PH
authors.lastname: Reitsma
authors.forename: H
authors.initials: H
authors.lastname: ten Cate
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001792:Blood Platelets / Q000648:ultrastructure*; D002784:Cholesterol / Q000097:blood; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006801:Humans; D039661:Integrin beta3 / Q000032:analysis / Q000187:drug effects*; D046911:Macromolecular Substances / Q000097:blood / Q000737:chemistry*; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation; D017035:Pravastatin / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D039661:Integrin beta3; D046911:Macromolecular Substances; D002784:Cholesterol; D017035:Pravastatin